CONTACT
+91 80 2808 2808
info@biocon.com
Biocon  /  Investor Relations  /  Shareholder Services  /  Miscellaneous Communication

MISCELLANEOUS COMMUNICATION

Extension of timelines (i) for nomination in eligible demat accounts and (ii) for submission of PAN, Nomination and KYC details by physical security holders; and voluntary nomination for trading accounts

download

Extension of timelines for providing ‘choice of nomination’ in eligible demat accounts

download

Form SH-13 (Nomination Form)

download

Form SH-14 (Cancellation or Variation of Nomination)

download

Form ISR-1

download

Form ISR-2

download

Form ISR-3

download

Form ISR-4

download

Furnishing of PAN, KYC details and Nomination by holders of physical securities

download

Generating awareness on availability of Dispute Resolution Mechanism at Stock Exchanges against Listed Companies/Registrar to an Issue and Share Transfer Agents (RTAs)

download

Model tripartite agreement between the issuer, existing share transfer agent and new share transfer agent

download

Redressal of investor grievances through the SEBI Complaint Redressal (SCORES) Platform and linking it to Online Dispute Resolution platform.

download

Reminder Letter to holders of physical securities for furnishing of PAN, KYC details and Nomination details

download

SEBI Circular

download
KEY MANAGEMENT TEAM
MEET OUR EMPLOYEES 
PRODUCTS
 PRESS RELEASES
BIOCON FOUNDATION
Share
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>